BioAxone is making great strides in developing products that will make a difference and change the world.
Research driven medical solutions is what we strive for. Our goal is changing lives in a healthier way.
Learn more about our company.
We have developed a number of proprietary product pipelines including BA-210, a variant of the C3 exoenzyme with great cell-penetration capabilities as well as Cethrin, a clinical treatment which uses BA-210 and a fibrin sealant to target spinal cord injuries. As well, at Bioaxone, we have begun development of BA-1049, which has shown promise in our medical research for reducing the proliferation of malignant cancer cells.
Innovation is what we do.
Research-driven medical solutions
Sustainability is Key